Bolt Biotherapeutics (BOLT) Short Interest Ratio & Short Volume $0.44 +0.02 (+4.76%) Closing price 03/26/2025 04:00 PM EasternExtended Trading$0.43 -0.01 (-2.27%) As of 03/26/2025 07:48 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipShort InterestTrendsBuy This Stock Bolt Biotherapeutics Short Interest DataBolt Biotherapeutics (BOLT) has a short interest of 24,300 shares, representing 0.10% of the float (the number of shares available for trading by the public). This marks a -37.53% decrease in short interest from the previous month. The short interest ratio (days to cover) is 0.2, indicating that it would take 0.2 days of the average trading volume of 172,414 shares to cover all short positions.Current Short Interest24,300 sharesPrevious Short Interest38,900 sharesChange Vs. Previous Month-37.53%Dollar Volume Sold Short$10,060.20Short Interest Ratio0.2 Days to CoverLast Record DateMarch 15, 2025Outstanding Shares38,273,000 sharesFloat Size25,200,000 sharesShort Percent of Float0.10%Today's Trading Volume254,156 sharesAverage Trading Volume172,414 sharesToday's Volume Vs. Average147% Short Selling Bolt Biotherapeutics? Sign up to receive the latest short interest report for Bolt Biotherapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartBOLT Short Interest Over TimeBOLT Days to Cover Over TimeBOLT Percentage of Float Shorted Over Time Remove Ads Bolt Biotherapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 3/15/202524,300 shares $10,060.20 -37.5%0.1%0.2 $0.41 2/28/202538,900 shares $18,458.05 -68.0%0.2%0.3 $0.47 2/15/2025121,400 shares $60,918.52 +14.4%0.5%0.8 $0.50 1/31/2025106,100 shares $51,989.00 -8.9%0.4%0.7 $0.49 1/15/2025116,400 shares $60,528.00 -3.8%0.5%0.7 $0.52 12/31/2024121,000 shares $64,747.10 +103.0%0.5%0.8 $0.54 12/15/202459,600 shares $31,462.84 -50.7%0.2%0.4 $0.53 11/30/2024120,900 shares $77,496.90 +19.2%0.5%0.8 $0.64 11/15/2024101,400 shares $57,341.70 +53.6%0.4%0.7 $0.57 10/31/202466,000 shares $41,890.20 -44.8%0.3%0.5 $0.63 Get the Latest News and Ratings for BOLT and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Bolt Biotherapeutics and its competitors with MarketBeat's FREE daily newsletter. 10/15/2024119,500 shares $75,285.00 +0.3%0.5%0.7 $0.63 9/30/2024119,100 shares $77,176.80 -39.1%0.5%0.7 $0.65 9/15/2024195,600 shares $119,061.72 -14.2%0.8%1.2 $0.61 8/31/2024228,000 shares $154,492.80 -6.2%0.9%1.4 $0.68 8/15/2024243,100 shares $167,982.10 -86.2%0.9%1.4 $0.69 7/31/20241,760,000 shares $1.32 million -3.3%7.3%6.4 $0.75 7/15/20241,820,000 shares $1.33 million -1.6%7.5%8.1 $0.73 6/30/20241,850,000 shares $1.39 million No Change7.7%8.4 $0.75 6/15/20241,850,000 shares $1.41 million -6.6%7.7%7.9 $0.76 5/31/20241,980,000 shares $1.50 million -7.0%8.2%8.5 $0.76 5/15/20242,130,000 shares $1.77 million +0.5%8.8%9.1 $0.83 4/30/20242,120,000 shares $2.34 million +1.9%8.8%16.8 $1.11 4/15/20242,080,000 shares $2.35 million +5.6%8.6%16.2 $1.13 3/31/20241,970,000 shares $2.76 million +0.5%8.2%16.3 $1.40 3/15/20241,960,000 shares $2.18 million +12.6%8.2%15.6 $1.11 2/29/20241,740,000 shares $1.98 million +7.4%7.3%13.7 $1.14 2/15/20241,620,000 shares $1.83 million No Change6.8%13.6 $1.13 1/31/20241,620,000 shares $1.64 million -1.2%6.8%15.1 $1.01 1/15/20241,640,000 shares $1.89 million No Change6.7%15.9 $1.15 12/31/20231,640,000 shares $1.84 million -0.6%6.7%15.5 $1.12 12/15/20231,650,000 shares $1.77 million +0.6%6.7%12.2 $1.07 11/30/20231,640,000 shares $1.40 million No Change6.7%13.9 $0.85 11/15/20231,640,000 shares $1.61 million +2.5%6.7%14.6 $0.98 10/31/20231,600,000 shares $1.57 million -3.0%6.6%14.6 $0.98 10/15/20231,650,000 shares $1.58 million +5.8%7.0%14.2 $0.96 9/30/20231,560,000 shares $1.62 million +0.7%6.6%13.8 $1.04 9/15/20231,550,000 shares $1.69 million +3.3%6.6%20.1 $1.09 8/31/20231,500,000 shares $1.65 million -12.3%6.4%16.1 $1.10 8/15/20231,710,000 shares $2.12 million +3.6%7.3%16.4 $1.24 7/31/20231,650,000 shares $2.23 million +5.8%7.0%12.3 $1.35The Trump Dump is starting; Get out of stocks now? (Ad)The first 365 days of the Trump presidency… Will be the best time to get rich in American history.If I’m right about this (like I was before) a modest $900 investment could grow to a life-changing a 7/15/20231,560,000 shares $2.12 million +0.7%6.7%10.7 $1.36 6/30/20231,550,000 shares $1.98 million No Change6.6%9.6 $1.28 6/15/20231,550,000 shares $2.34 million +2.0%6.6%7 $1.51 5/31/20231,520,000 shares $2.61 million +1.3%6.5%6.8 $1.72 5/15/20231,500,000 shares $2.93 million No Change6.4%6.3 $1.95 4/30/20231,500,000 shares $2.37 million +0.7%6.2%6 $1.58 4/15/20231,490,000 shares $2.18 million -4.5%6.2%5.9 $1.46 3/31/20231,560,000 shares $2.17 million +4.0%6.5%6.3 $1.39 3/15/20231,500,000 shares $2.19 million No Change6.2%5.3 $1.46 2/28/20231,500,000 shares $2.42 million -11.8%6.2%5.2 $1.61 2/15/20231,700,000 shares $2.38 million +0.6%7.1%5.8 $1.40 1/31/20231,690,000 shares $2.48 million +0.6%7.0%5.8 $1.47 1/15/20231,680,000 shares $2.52 million -3.5%7.0%6 $1.50 12/30/20221,740,000 shares $2.26 million -1.1%7.2%6.6 $1.30 12/15/20221,760,000 shares $2.32 million -1.7%8.6%10.1 $1.32 11/30/20221,790,000 shares $2.65 million +9.2%8.8%11 $1.48 11/15/20221,640,000 shares $2.10 million +43.9%8.1%11.9 $1.28 10/31/20221,140,000 shares $1.58 million +3.6%5.4%10.3 $1.39 10/15/20221,100,000 shares $1.54 million -1.8%5.2%10 $1.40 9/30/20221,120,000 shares $1.66 million +18.1%5.3%8.9 $1.48 9/15/2022948,500 shares $1.72 million +29.2%4.5%4.9 $1.81 8/31/2022734,300 shares $1.32 million +5.5%3.5%3.3 $1.80 8/15/2022695,900 shares $1.54 million +11.0%3.3%2.8 $2.21 7/31/2022627,000 shares $1.36 million -25.7%3.0%2.2 $2.17 7/15/2022843,300 shares $2.13 million -11.5%4.1%2.7 $2.53 6/30/2022953,300 shares $1.94 million -42.6%4.6%2.9 $2.04 6/15/20221,660,000 shares $2.97 million -8.8%8.0%5.5 $1.79 5/31/20221,820,000 shares $3.09 million +11.7%8.8%7.4 $1.70 5/15/20221,630,000 shares $2.48 million +0.6%7.9%6.7 $1.52 4/30/20221,620,000 shares $2.53 million +40.9%7.7%6.9 $1.56 4/15/20221,150,000 shares $2.89 million -8.0%5.5%5.5 $2.51 3/31/20221,250,000 shares $3.43 million -6.7%6.0%5.6 $2.74 3/15/20221,340,000 shares $3.83 million -63.6%6.4%5.5 $2.86 2/28/20223,680,000 shares $12.84 million -15.4%17.7%10 $3.49 2/15/20224,350,000 shares $13.49 million +1.4%20.9%10.9 $3.10 1/31/20224,290,000 shares $16.47 million +2.4%20.9%10.9 $3.84 1/15/20224,190,000 shares $16.59 million -0.2%20.3%11.4 $3.96 12/31/20214,200,000 shares $20.58 million -0.9%20.4%12.2 $4.90 12/15/20214,240,000 shares $18.87 million -2.8%20.6%13.5 $4.45 11/30/20214,360,000 shares $40.42 million +0.7%21.2%13.8 $9.27 11/15/20214,330,000 shares $43.13 million +1.4%21.0%20.5 $9.96 10/29/20214,270,000 shares $55.89 million -0.7%21.0%21.8 $13.09 10/15/20214,300,000 shares $58.01 million No Change21.1%21.5 $13.49 9/30/20214,300,000 shares $54.40 million +28.4%21.1%21.5 $12.65 9/15/20213,350,000 shares $53.57 million +15.5%18.2%15.3 $15.99 8/31/20212,900,000 shares $51.50 million +23.9%16.0%15.9 $17.76 8/13/20212,340,000 shares $30.16 million No Change12.9%13.7 $12.89 BOLT Short Interest - Frequently Asked Questions What is Bolt Biotherapeutics' current short interest? Short interest is the volume of Bolt Biotherapeutics shares that have been sold short but have not yet been closed out or covered. As of March 15th, investors have sold 24,300 shares of BOLT short. 0.10% of Bolt Biotherapeutics' shares are currently sold short. Learn More on Bolt Biotherapeutics' current short interest. What is a good short interest percentage for Bolt Biotherapeutics? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.10% of Bolt Biotherapeutics' floating shares are currently sold short. Is Bolt Biotherapeutics' short interest increasing or decreasing? Bolt Biotherapeutics saw a drop in short interest in the month of March. As of March 15th, there was short interest totaling 24,300 shares, a drop of 37.5% from the previous total of 38,900 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Bolt Biotherapeutics' float size? Bolt Biotherapeutics currently has issued a total of 38,273,000 shares. Some of Bolt Biotherapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Bolt Biotherapeutics currently has a public float of 25,200,000 shares. How does Bolt Biotherapeutics' short interest compare to its competitors? 0.10% of Bolt Biotherapeutics' shares are currently sold short. Here is how the short interest of companies in the industry of "biotechnology" compare to Bolt Biotherapeutics: Dominari Holdings Inc. (3.55%), Fortress Biotech, Inc. (19.11%), Agenus Inc. (14.71%), Curis, Inc. (1.93%), SAB Biotherapeutics, Inc. (1.55%), Molecular Templates, Inc. (5.48%), Amgen Inc. (2.81%), Gilead Sciences, Inc. (1.80%), Vertex Pharmaceuticals Incorporated (2.25%), Regeneron Pharmaceuticals, Inc. (3.21%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Invesco QQQ ($26.28 billion), iShares 20+ Year Treasury Bond ETF ($9.53 billion), MicroStrategy Incorporated ($8.50 billion), Apollo Global Management, Inc. ($4.86 billion), Super Micro Computer, Inc. ($4.85 billion), Charter Communications, Inc. ($4.28 billion), Capital One Financial Co. ($4.08 billion), AppLovin Co. ($3.82 billion), Canadian Natural Resources Limited ($3.78 billion), and Schlumberger Limited ($2.87 billion). View all of the most shorted stocks. What does it mean to sell short Bolt Biotherapeutics stock? Short selling BOLT is an investing strategy that aims to generate trading profit from Bolt Biotherapeutics as its price is falling. BOLT shares are trading up $0.02 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Bolt Biotherapeutics? A short squeeze for Bolt Biotherapeutics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of BOLT, which in turn drives the price of the stock up even further. How often is Bolt Biotherapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including BOLT, twice per month. The most recent reporting period available is March, 15 2025. More Short Interest Resources from MarketBeat Related Companies Dominari Short Interest Fortress Biotech Short Interest Agenus Short Interest Curis Short Interest SAB Biotherapeutics Short Interest Molecular Templates Short Interest Amgen Short Interest Gilead Sciences Short Interest Vertex Pharmaceuticals Short Interest Regeneron Pharmaceuticals Short Interest Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:BOLT) was last updated on 3/27/2025 by MarketBeat.com Staff From Our PartnersA market crash is coming—here’s whenThe stock market cycle I've used to identify the most likely day of the next market crash is the exact same in...Chaikin Analytics | SponsoredYour Wealth is Under AttackPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | SponsoredA brutally honest economic warning for 2025 (see proof)New York Times best-selling financial author and world-renowned economist Addison Wiggin (a man who’s worked s...Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredEx CIA predicts 40% “double crash” – April 11The scientists here don’t study deadly viruses… directed energy weapons… or even weather control technology… ...Paradigm Press | Sponsored“Amazon Coin” set to outperform BitcoinChris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Bolt Biotherapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Bolt Biotherapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy BOLT Stock Free BOLT Stock Alerts